Kanowith-Klein S, Saxon A, Uittenbogaart C H
Eur J Immunol. 1987 May;17(5):593-8. doi: 10.1002/eji.1830170503.
A lymphokine demonstrating human B cell differentiation factor (BCDF)-like activity was isolated from immature (MOLT-4f, CCRF-CEM and CCRF-HSDB-2) and mature (HUT-78) malignant human T lymphoid cell lines and from human B lymphoblastoid cell lines (BJAB and ALL-7031-B). All the cell lines were grown long term in serum-free medium. This BCDF-like activity has a molecular mass in the range of 40-60 kDa and stimulates immunoglobulin synthesis of cell lines capable of producing IgA (GM-1056), IgG (GM-1500 and CESS) and IgM (CBL#3). It was not produced by a myeloid cell line. We were only able to identify the differentiation activity produced by the T and B cell lines by using appropriate molecular mass fractions from the serum-free medium as controls. This BCDF-like activity is different from that of the human BCDF so far described as it has a higher molecular mass and is constitutively produced by malignant T lymphoid cell lines which are human T cell leukemia virus-I negative and by B lymphoblastoid cell lines.
从人未成熟恶性T淋巴细胞系(MOLT-4f、CCRF-CEM和CCRF-HSDB-2)及成熟恶性T淋巴细胞系(HUT-78)和人B淋巴母细胞系(BJAB和ALL-7031-B)中分离出一种具有人B细胞分化因子(BCDF)样活性的淋巴因子。所有细胞系均长期在无血清培养基中培养。这种BCDF样活性的分子量在40 - 60 kDa范围内,可刺激能够产生IgA(GM-1056)、IgG(GM-1500和CESS)和IgM(CBL#3)的细胞系合成免疫球蛋白。它不是由髓系细胞系产生的。我们只能通过使用无血清培养基中适当分子量级分作为对照来鉴定T和B细胞系产生的分化活性。这种BCDF样活性与迄今所描述的人BCDF不同,因为它具有更高的分子量,并且由人T细胞白血病病毒-I阴性的恶性T淋巴细胞系和B淋巴母细胞系组成性产生。